down arrow

Gufic BioScience

30
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
322.15
8.85 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 26.3 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Gufic BioScience Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
No of Months
12
Profit Before Tax
86.00
Adjustment
63.00
Changes In working Capital
-130.00
Cash Flow after changes in Working Capital
19.00
Cash Flow from Operating Activities
-7.00
Cash Flow from Investing Activities
-102.00
Cash Flow from Financing Activities
82.00
Net Cash Inflow / Outflow
-27.00
Opening Cash & Cash Equivalents
28.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
Effect of Foreign Exchange Fluctuations
0.00
Closing Cash & Cash Equivalent
1.00
Compare Cash Flow Results of Gufic BioScience
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
86.14
2399.36
-2,313.00
-96.41%
Adjustment
63.68
212.2
-149.00
-69.99%
Changes In working Capital
-130.23
20.42
-150.00
-737.76%
Cash Flow after changes in Working Capital
19.59
2631.98
-2,612.00
-99.26%
Cash Flow from Operating Activities
-7.46
2152.45
-2,159.00
-100.35%
Cash Flow from Investing Activities
-102.39
-2080.52
1,978.00
95.08%
Cash Flow from Financing Activities
82.38
5.27
77.00
1463.19%
Net Cash Inflow / Outflow
-27.47
77.19
-104.00
-135.59%
Opening Cash & Cash Equivalents
28.6
304.82
-276.00
-90.62%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1.14
382.01
-381.00
-99.70%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

Not Applicable: The company has declared_date for only one period

Mar'24
Change(%)
Cash Flow from Operating Activities
-7.46
NA
NA